Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

BACKGROUND: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is secreted from bone and serum level increases as renal function declines. Higher levels of FGF23 are associated with increased mortality in hemodialysis-patients and in patients with chronic kidney disease (CKD) stage 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleskestad, Inger H, Bergrem, Harald, Hartmann, Anders, Godang, Kristin, Gøransson, Lasse G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462711/
https://www.ncbi.nlm.nih.gov/pubmed/22742720
http://dx.doi.org/10.1186/1471-2369-13-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462711/
https://www.ncbi.nlm.nih.gov/pubmed/22742720
http://dx.doi.org/10.1186/1471-2369-13-49

Ejemplares similares